Gts Securities LLC Bio N Tech Se Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $540,684 - $860,154	-6,900 Reduced 15.1%	38,800 $4.61 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $996,464 - $1.28 Million	-12,400 Reduced 21.34%	45,700 $3.67 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $1.71 Million - $2.16 Million	-19,200 Reduced 24.84%	58,100 $5.36 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $2.1 Million - $2.6 Million	-23,100 Reduced 23.01%	77,300 $8.16 Million
Q3 2023 Nov 15, 2023	BUY	$98.5 - $125.08 $9.89 Million - $12.6 Million	100,400 New	100,400 $10.9 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.